JAK2 MUTATION, TNF-Α AND IL 6 PREDICT RESPONSE TO JAK INHIBITOR IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Hussein, Y. Adel Abdelsalam [1 ]
Sadeq, Y. [2 ]
机构：
[1] Mansoura Univ Hosp, Rheumatol, Mansoura, Egypt
[2] Mansoura Univ Hosp, Clin Pathol, Mansoura, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Prognostic factors;
D O I：
10.1136/annrheumdis-2023-eular.840
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0358
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [41] Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
    Lauper, Kim
    Ludici, Michele
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    Cordtz, Rene
    De Cock, Diederik
    Dreyer, Lene
    Elkayam, Ori
    Hauge, Ellen-Margrethe
    Huschek, Doreen
    Hyrich, Kimme L.
    Iannone, Florenzo
    Inanc, Nevsun
    Kearsley-Fleet, Lianne
    Kristianslund, Eirik Klami
    Kvien, Tore K.
    Leeb, Burkhard F.
    Lukina, Galina
    Nordstrom, Dan C.
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Santos, Maria Jose
    Strangfeld, Anja
    Verschueren, Patrick
    Courvoisier, Delphine Sophie
    Finckh, Axel
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10) : 1358 - 1366
  • [42] Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
    Ma, Wanlong
    Kantarjian, Hagop
    Zhang, Xi
    Yeh, Chen-Hsiung
    Zhang, Zhong J.
    Verstovsek, Srdan
    Albitar, Maher
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (01): : 49 - 53
  • [43] Models to Predict Response to JAK-inhibitor Therapy in Patients with Myelofibrosis
    Menghrajani, Kamal
    Boonstra, Philip
    Perkins, Cecelia
    Gowin, Krisstina
    Weber, Alissa
    Mesa, Ruben
    Gotlib, Jason
    Wang, Lixia
    Singer, Jack
    Talpaz, Moshe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S358 - S359
  • [44] The JAK2 V617F mutation in patients with anaemia
    Langabeer, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
  • [45] Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors
    Wonho Choi
    Soo Min Ahn
    Yong-Gil Kim
    Chang-Keun Lee
    Bin Yoo
    Seokchan Hong
    Clinical Rheumatology, 2022, 41 : 1659 - 1663
  • [46] Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors
    Choi, Wonho
    Ahn, Soo Min
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    CLINICAL RHEUMATOLOGY, 2022, 41 (06) : 1659 - 1663
  • [47] JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
    Santos, Fabio P. S.
    Verstovsek, Srdan
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 1098 - 1109
  • [48] Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 589 - 590
  • [49] Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis
    Mascarenhas, John
    Baer, Maria R.
    Kessler, Craig
    Hexner, Elizabeth
    Tremblay, Douglas
    Price, Leah
    Sandy, Lonette
    Weinberg, Rona
    Pahl, Heike
    Silverman, Lewis R.
    Goldberg, Judith D.
    Kosiorek, Heidi
    Dueck, Amylou C.
    Hoffman, Ronald
    LEUKEMIA & LYMPHOMA, 2019, 60 (05) : 1343 - 1345
  • [50] RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, S. R.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 716
12345